Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06000813 · ClinicalTrials.gov registry record · NA
REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
A NA study of Medication Adherence and Type 2 Diabetes (Adult Onset), sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06000813 is a NA study of Medication Adherence and Type 2 Diabetes (Adult Onset) that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 70 participants, below the 1,655-participant average among 52 other Medication Adherence trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06000813, a NA study of Medication Adherence and Type 2 Diabetes (Adult Onset), is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The proposed project will test an interactive text message-based tool tailored to address barriers to taking diabetes medications that are relevant to Latino adults. If found feasible, acceptable, and usable, this intervention could serve as a scalable tool to improve diabetes management and reduce diabetes-related complications among Latino adults in the United States.
Conditions Studied
Interventions
- BEHAVIORAL ETAU
- BEHAVIORAL REACH-Es
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Diabetes Research Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06000813
The ClinicalTrials.gov registry entry for NCT06000813 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,655-participant average among 52 other Medication Adherence trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 2 interventions - of which ETAU is the first listed.
NCT06000813 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06000813 about?
NCT06000813 is a clinical study titled "REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults". Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The proposed project wi...
What is the current status of trial NCT06000813?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-06-18. Estimated completion is 2027-02-28.
What conditions does trial NCT06000813 study?
This clinical trial studies the following conditions: Medication Adherence, Type 2 Diabetes (Adult Onset).
What interventions are being tested in trial NCT06000813?
The interventions under investigation include: ETAU (BEHAVIORAL), REACH-Es (BEHAVIORAL).
Who is sponsoring clinical trial NCT06000813?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06000813 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Adherence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Medication Adherence Program
RECRUITING · NA
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
RECRUITING · NA
-
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
RECRUITING · NA
-
Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.